glp 1 and kidney Potential renoprotective effects of GLP1 receptor agonists. The GLP-1 Receptor Agonists in the

New Level II HCPCS Codes Final Rule Comment Solicitation Consistent with past practice, we are soliciting comments on the new Level II HCPCS codes that will be effective January 1, 2026, in the CY 2026 OPPS/ASC final rule with comment period, thereby allowing us to finalize the status indicators and APC assignments for the codes in the CY 2027 OPPS/ASC final rule with comment period

Immune checkpoint inhibitor-related hearing loss: a systematic review and analysis of individual patient data

In the pursuit of weight loss with GLP-1 therapy, hydration emerges as an indispensable ally, nurturing wellness and optimizing outcomes

10.3390/antiox11081419 130

Women with diabetes who used GLP-1 agonists saw an even greater risk reduction compared with those who used insulin or metformin, but there was no significant difference when comparing GLP-1 meds and SGLT2 inhibitors